Sort
48,018 grants matching “immunotherapy”
Transfusion Biology and Medicine
$477,533Leslie Eric Silberstein · Boston Children'S Hospital · T32 · FY2008 · HL
Mucosal T cell memory to pathogens
$477,507David Masopust · University Of Minnesota · R01 · FY2021 · AI
Mucosal T cell memory to pathogens
$477,507David Masopust · University Of Minnesota · R01 · FY2022 · AI
Mucosal T cell memory to pathogens
$477,507David Masopust · University Of Minnesota · R01 · FY2023 · AI
Exploring the potential of TET inhibition in cancer immunotherapy
$477,498Anjana Rao · La Jolla Institute For Immunology · R01 · FY2024 · CA
Two Compartment Models to Improve Brain Tumor Therapy
$477,492Edward A Neuwelt · Oregon Health & Science University · R01 · FY2015 · CA
Nanoscale delivery vehicles for antigen-based vaccines
$477,423Jean M Frechet · University Of California Berkeley · R01 · FY2007 · EB
Immunomodulation targeting abnormal conformation and the influence of apoE
$477,410Fernando Goni · New York University School Of Medicine · P01 · FY2020 · AG
HIV Molecular Biology and Pathogenic Mechanisms of AIDS
$477,388George N. Pavlakis · Basic Sciences · Z01 · FY2007 · CA
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
$477,379Dai Fukumura · Massachusetts General Hospital · R01 · FY2018 · CA
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
$477,379Dai Fukumura · Massachusetts General Hospital · R01 · FY2020 · CA
Nanoscale delivery vehicles for antigen-based vaccines
$477,361Jean M Frechet · University Of California Berkeley · R01 · FY2006 · EB
Gonorrhea and HIV prevention with intravaginal ring drug delivery
$477,355Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R33 · FY2022 · AI
The function of PLZF in innate T cells
$477,250Derek B. Sant'angelo · Sloan-Kettering Inst Can Research · R01 · FY2010 · AI
PROOF-OF-CONCEPT STUDIES FOR A NOVEL IMMUNOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER AND COMPANION DIAGNOSTIC
$477,231The Council Of The Queensland Institute Of Medical Research · · FY2025 · Defense Health Agency
qHTS of Patient Derived HCC Models to Identify Novel Probes/Therapeutic Agents
$477,136Paul A. Johnston · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
The development of Saccharomyces (yeast) vaccines for cancer therapy
$477,129James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Inhibitory Pathways Underlying Viral Persistence In Vivo
$477,070Elina I Zuniga · University Of California, San Diego · R01 · FY2016 · AI
Immunotherapy for Drug Abuse
$477,066S. Michael Owens · Univ Of Arkansas For Med Scis · R01 · FY2007 · DA
The role of sex in the life cycle and transmission of Pneumocystis
$477,062Melanie T Cushion · University Of Cincinnati · R01 · FY2020 · HL
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
$477,009Rick L Tarleton · University Of Georgia · R01 · FY2021 · AI
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
$477,009Rick L Tarleton · University Of Georgia · R01 · FY2020 · AI
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
$477,009Rick L Tarleton · University Of Georgia · R01 · FY2023 · AI
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
$477,009Rick L Tarleton · University Of Georgia · R01 · FY2022 · AI
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
$477,009Rick L Tarleton · University Of Georgia · R01 · FY2024 · AI